Inhibition of class-3 aldehyde dehydrogenase and cell growth by restored lipid peroxidation in hepatoma cell lines

Free Radical Biology and Medicine

Volumn 26, Issue 3-4, 1999, Pages 333-340

  Canuto, Rosa A ^a   Muzio, Giuliana ^a   Ferro, Margherita ^b   Maggiora, Marina ^a   Federa, Rosanna ^b   Bassi, Anna M ^b   Lindahl, Ronald ^c   Dianzani, Mario U ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

Aldehyde dehydrogenase; Arachidonic acid; Ascorbate iron sulphate; Free radical; Hepatoma; Lipid peroxidation; MDA production

Indexed keywords

ALDEHYDE DEHYDROGENASE;

ARTICLE; CELL GROWTH; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; HEPATOMA CELL; HUMAN; HUMAN CELL; LIPID ANALYSIS; LIPID PEROXIDATION; PRIORITY JOURNAL;

EID: 0032957410     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(98)00206-8     Document Type: Article

References (44)

1. Bartoli G.M., Bartoli S., Galeotti T., Bertoli E. Superoxide dismutase content and microsomal lipid composition of tumours with different growth rate. Biochim. Biophys. Acta. 620:1980;205-211.
2. Cheeseman K.H., Emery S., Maddix S.P., Slater T.F., Burton G-W, Ingold K.U. Studies on lipid peroxidation in normal and tumour tissues. The Yoshida rat liver tumour. Biochem. J. 250:1988;247-252.
3. Mahler S.M., Wilce P.A., Shanley B.C. Studies on regenerating liver and hepatoma plasma membranes-I. Lipid and protein composition. Int. J. Biochem. 20:1988;605-611.
4. Canuto R.A., Muzio G., Biocca M.E., Dianzani M.U. Oxidative metabolism of 4-hydroxy-2,3-nonenal during diethyl-nitrosamine-induced carcinogenesis in rat liver. Cancer Lett. 46:1989;7-13.
5. Canuto R.A., Muzio G., Biocca M.E., Dianzani M.U. Lipid peroxidation in rat AH-130 hepatoma cells enriched in vitro with arachidonic acid. Cancer Res. 51:1991;4603-4608.
6. Canuto R.A., Ferro M., Muzio G., Bassi A.M., Leonarduzzi G., Maggiora M., Adamo D., Poli G., Lindahl R. Role of aldehyde metabolizing enzymes in mediating effects of aldehyde products of lipid peroxidation in liver cells. Carcinogenesis. 15:1994;1359-1364.
7. Lopez-Saura P., Trouet A., Tulkens P. Analytical fractionation of cultured hepatoma cells (HTC cells). Biochim. Biophys. Acta. 543:1978;430-449.
8. Canuto R.A., Paradisi L., Muzio G., Maggiora M., Mengozzi G., Garramone A., Dianzani M.U. Changes of adenylate cyclase activity in AH-130 ascites hepatoma of Yoshida induced by enrichment with fatty acids. Biochem. Biophys. Res. Commun. 213:1995;853-860.
9. Masotti L., Casali E., Galeotti T. Lipid peroxidation in tumour cells. Free Radic. Biol. Med. 4:1988;377-386.
10. Bunting K.D., Lindahl R., Townsend A.J. Oxazaphosphorine-specific resistance in human MCF-7 Breast carcinoma cell lines expressing transfected rat Class-3 aldehyde dehydrogenase. J. Biol. Chem. 269:1994;23197-23203.
11. r 54,000 is an aldehyde dehydrogenase and is down-regulated in mouse liver tumors and in tumor cell lines. Mol. Pharmacol. 46:1994;896-900.
12. Rekha G.K., Sreerama L., Sladek N.E. Intrinsic cellular resistance to oxazaphosphorines exhibited by a human colon carcinoma cell line expressing relatively large amounts of a Class-3 aldehyde dehydrogenase. Biochem. Pharmacol. 48:1994;1943-1952.
13. Sreerama L., Rekha G.K., Sladek N.E. Phenolic antioxidant-induced overexpression of Class-3 aldehyde dehydrogenase and oxazaphosphorine-specific resistance. Biochem. Pharmacol. 49:1995;669-675.
14. Soldan M., Maser E. Metabolic inactivation and efflux of daunorubicin as complementary mechanisms in tumor cell protection. Adv. Exp. Med. Biol. 414:1996;537-544.
15. Lindahl R. Aldehyde dehydrogenase and their role in carcinogenesis. Critical Rev. Biochem. Mol. Biol. 27:1992;283-335.
16. Chieco P., Stecca B., Bolondi L., Melchiorri C., Gaiani S., Barbara L. Cytochemical detection of a Class-3 aldehyde dehydrogenase in human hepatocellular carcinoma. Liver. 15:1995;87-92.
17. Sreerama L., Sladek N.E. Over-expression of glutathione S-transferases, Dt-diaphorase and an apparently tumor-specific cytosolic Class-3 aldehyde dehydrogenase by Warthin tumours and mucoepidermoid carcinomas of the human parotid gland. Archs. Oral Biol. 41:1996;597-605.
18. Lee M.O., Manthey C.L., Sladek N.E. Identification of mouse liver aldehyde dehydrogenases that catalyze the oxidation of retinaldehyde to retinoic acid. Biochem. Pharmacol. 42:1991;1279-1285.
19. Sreerama L., Sladek N.E. Identification and characterization of a novel class 3 aldehyde dehydrogenase overexpressed in a human breast adenocarcinoma cell line exhibiting oxazaphosphorine-specific acquired resistance. Biochem Pharmacol. 45:1993;2487-2505.
20. Bunting K.D., Townsend A.J. De novo expression of transfected human class 1 aldehyde dehydrogenase (ALDH) causes resistance to oxazaphosphorine anti-cancer alkylating agents in hamster V79 cell lines. Elevated class 1 ALDH activity is closely correlated with reduction in DNA interstrand cross-linking and lethality. J. Biol. Chem. 271:1996;11884-11890.
21. Magni M., Shammah S., Schiro R., Mellado W., Dalla-Favera R., Gianni A.M. Induction of cyclophosphamide-resistance by aldehyde-dehydrogenase gene transfer. Blood. 87:1996;1097-1103.
22. Kohn F.R., Sladek N.E. Aldehyde dehydrogenase activity as the basis for the relative insensitivity of murine pluripotent hematopoietic stem cells to oxazaphosphorines. Biochem. Pharmacol. 34:1985;3465-3471.
23. Kohn F.R., Landkamer G.J., Manthey C.L., Ramsay N.K.C., Sladek N.E. Effect of aldehyde dehydrogenase inhibitors on the ex Vivo sensitivity of human multipotent and committed hematopoietic progenitor cell and malignant blood cells to oxazaphosphorines. Cancer Res. 47:1987;3180-3185.
24. Moreb J., Zucali J.R., Zhang Y., Colvin M.O., Gross M.A. Role of aldehyde dehydrogenase in the protection of hematopoietic progenitor cells from 4-hydroperoxycyclophosphamide by interleukin 1β and tumor necrosis factor. Cancer Res. 52:1992;1770-1774.
25. Poli G., Cecchini G., Biasi F., Chiarpotto E., Canuto R.A., Biocca M.E., Muzio G., Esterbauer H., Dianzani M.U. Resistance to oxidative stress by hyperplastic and neoplastic rat liver tissue monitored in terms of production of unpolar and medium polar carbonyls. Biochim. Biophys. Acta. 883:1986;207-214.
26. Canuto R.A., Muzio G., Bassi A.M., Maggiora M., Leonarduzzi G., Lindahl R., Dianzani M.U., Ferro M. Enrichment of arachidonic acid increases the sensitivity of hepatoma cells to the cytotoxic effects of oxidative stress. Free Radic. Biol. Med. 18:1995;287-293.
27. Folch J., Lees M., Sloane Stanley G. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226:1957;497-509.
28. Metcalfe L.D., Pelka J.R., Schmitz A.A. Rapid preparation of fatty acid esters for gas chromatographyc analysis. Anal. Chem. 38:1966;514-515.
29. Kornberg A. Lactic dehydrogenase of muscle. Colowick S.P., Kaplan N.D. Methods of Enzymology. Vol. 1:1955;441-443 Academic Press, New York.
30. Gornal A.G., Bardawill C.J., David M. Determination of serum proteins by means of the biuret reaction. J. Biol. Chem. 177:1949;751-766.
31. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
32. Takimoto K., Lindahl R., Pitot H.C. Regulation of 2,3,7,8-tetrachloridibenzo-p-dioxin-inducible expression of aldehyde dehydrogenase in hepatoma cells. Arch. Biochem. Biophys. 298:1992;492-497.
33. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocynate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
34. Barrera G., Muraca R., Pizzimenti S., Serra A., Rosso C., Saglio G., Farace M.G., Fazio V.M., Dianzani M.U. Inhibition of c-myc expression induced by 4-hydroxynonenal, a product of lipid peroxidation, in the HL-60 human leukemic cell line. Biochem. Biophys. Res. Commun. 203:1994;553-561.
35. Barrera G., Pizzimenti S., Serra A., Ferretti C., Fazio V.M., Saglio G., Dianzani M.U. 4-hydroxynonenal specifically inhibits c-myb but does not affect c-fos expressions in HL-60 cells. Biochem. Biophys. Res. Commun. 227:1996;589-593.
36. Fazio V.M., Barrera G., Martinotti S., Farace M.G., Giglioni B., Frati L., Manzari V., Dianzani M.U. 4-hydroxynonenal, a product of cellular lipid peroxidation, which modulates c-myc and globin gene expression in K562 cells. Cancer Res. 52:1992;4866-4871.
37. Spycher S., Tabataba-Vakili S., O'Donnell V.B., Palomba L., Azzi A. 4-hydroxy-2,3-trans-nonenal induces transcription and expression of aldose reductase. Biochem. Biophys. Res. Commun. 226:1996;512-516.
38. Huang M., Lindahl R. Effects of hepatocarcinogenic initiators on aldehyde dehydrogenase gene expression in cultured rat hepatic cells. Carcinogenesis. 11:1990;1059-1065.
39. Hartley D.P., Lindahl R., Petersen D.R. Covalent modification of Class 2 and Class 3 aldehyde dehydrogenase by 4-hydroxynonenal. Adv. Exp. Med. Biol. 372:1995;93-101.
40. Benchekroun M.N., Pourquier P., Schott B., Robert J. Doxorubicin-induced lipid peroxidation and glutathione peroxidase activity in tumor cell lines selected for resistance to doxorubicin. Eur. J. Biochem. 211:1993;141-146.
41. R-8-5 tumor cell drug-resistance by cis-unsatured fatty acids in vitro. Med. Sci. Res. 22:1994;689-692.
42. Shao Y., Pardini L., Pardini R.S. Enhancement of the antineoplastic effect of mitomycin C by dietary fat. Cancer Res. 54:1994;6452-6457.
43. Zerouga M., Stillwell W., Powner A., Jenski L.J. Phospholipid class as a determinant in docosahexaenoic acid's effect on tumor cell viability. Anticancer Res. 16:1996;2863-2868.
44. Brekke O.-L., Espevik T., Bardal T., Bjerve K.S. Effects of n-3 and n-6 fatty acids on tumor necrosis factor cytotoxicity in WEHI fibrosarcoma cells. Lipids. 27:1992;161-168.